Journal of International Obstetrics and Gynecology ›› 2023, Vol. 50 ›› Issue (5): 522-525.doi: 10.12280/gjfckx.20230567

• Obstetric Physiology & Obstetric Disease: Case Report • Previous Articles     Next Articles

Complete Hydatidiform Mole with Co-Existing Fetus: A Case Report and Literature Review

LI Jian, WANG Guan   

  1. Department of Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics / Nankai University Maternity Hospital, Tianjin 300199, China; Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin 300199, China
  • Received:2023-07-22 Published:2023-10-15 Online:2023-10-16

Abstract:

Hydatidiform mole and co-existing fetus (HMCF) is a rare obstetric disease, including complete hydatidiform mole with co-existing fetus (CHMCF) and partial hydatidiform mole with a co-existing fetus (PHMCF). A case of CHMCF was reported by continuous monitoring of thyroid function, human chorionic gonadotropin and fetal status during pregnancy up to 37 weeks of gestation and delivery of a live infant by cesarean section. CHMCF is a clinically rare and high-risk disease. Therefore, pregnancy, parturition and postpartum follow-up should be carefully diagnosed and closely monitored through ultrasound, magnetic resonance imaging (MRI) and chromosomal karyotype analysis in institutions with prenatal diagnosis and gynecological oncology centers.

Key words: Pregnancy, twin, Hydatidiform mole, Gestational trophoblastic disease, Karyotyping, Complete hydatidiform mole with co-existing fetus